Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Gastric Cancer

  Free Subscription

Articles published in Cancer Lett

Retrieve available abstracts of 38 articles:
HTML format

Single Articles

    April 2023
  1. LI M, Mei YX, Wen JH, Jiao YR, et al
    Hepatoid adenocarcinoma-Clinicopathological features and molecular characteristics.
    Cancer Lett. 2023;559:216104.
    PubMed     Abstract available

    February 2023
  2. YANG J, Xu P, Chen Z, Zhang X, et al
    N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer.
    Cancer Lett. 2023;558:216092.
    PubMed     Abstract available

    December 2022
  3. CHEN T, Chen J, Zeng T, Huang Q, et al
    WZ35 inhibits gastric cancer cell metastasis by depleting glutathione to promote cellular metabolic remodeling.
    Cancer Lett. 2022 Dec 24:216044. doi: 10.1016/j.canlet.2022.216044.
    PubMed     Abstract available

  4. ZHENG W, Yang Z, Song P, Sun Y, et al
    SHP2 inhibition mitigates adaptive resistance to MEK inhibitors in KRAS-mutant gastric cancer through the suppression of KSR1 activity.
    Cancer Lett. 2022 Dec 6:216029. doi: 10.1016/j.canlet.2022.216029.
    PubMed     Abstract available

    November 2022
  5. XU Y, Lu J, Tang Y, Xie W, et al
    Retraction notice to "PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages" [Cancer Lett. 529 (2022) 19-36].
    Cancer Lett. 2022;549:215931.
    PubMed     Abstract available

    October 2022
  6. YONG X, Tang B, Xiao YF, Xie R, et al
    Corrigendum to "Helicobacter pylori upregulates Nanog and Oct4 via Wnt/beta-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer" [Canc. Lett. 374 (2016) 292-303].
    Cancer Lett. 2022 Oct 21:215961. doi: 10.1016/j.canlet.2022.215961.

    September 2022
  7. WANG S, Wo L, Zhang Z, Zhu C, et al
    Delivery of LINC00589 via mesoporous silica nanoparticles inhibits peritoneal metastasis in gastric cancer.
    Cancer Lett. 2022 Sep 17:215916. doi: 10.1016/j.canlet.2022.215916.
    PubMed     Abstract available

    August 2022
  8. ZHANG JY, Du Y, Gong LP, Shao YT, et al
    Corrigendum to "ebv-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3 [Cancer Letters 535 (2022) 215646]''.
    Cancer Lett. 2022 Aug 4:215824. doi: 10.1016/j.canlet.2022.215824.

    July 2022
  9. HE D, Chen M, Chang L, Gu J, et al
    De novo pyrimidine synthesis fuels glycolysis and confers chemoresistance in gastric cancer.
    Cancer Lett. 2022 Jul 31:215837. doi: 10.1016/j.canlet.2022.215837.
    PubMed     Abstract available

  10. WANG M, Cai W, Yang AJ, Wang CY, et al
    Gastric cancer cell-derived extracellular vesicles disrupt endothelial integrity and promote metastasis.
    Cancer Lett. 2022 Jul 13:215827. doi: 10.1016/j.canlet.2022.215827.
    PubMed     Abstract available

  11. HU F, Peng Y, Chang S, Luo X, et al
    Vimentin binds to a novel tumor suppressor protein, GSPT1-238aa, encoded by circGSPT1 with a selective encoding priority to halt autophagy in gastric carcinoma.
    Cancer Lett. 2022 Jul 12:215826. doi: 10.1016/j.canlet.2022.215826.
    PubMed     Abstract available

    June 2022
  12. ZENG S, Xie X, Xiao YF, Tang B, et al
    Corrigendum to "Long noncoding RNA LINC00675 enhances phosphorylation of vimentin on Ser83 to suppress gastric cancer progression" [Cancer Lett. 2018 Jan 1;412:179-187].
    Cancer Lett. 2022 Jun 24:215805. doi: 10.1016/j.canlet.2022.215805.

  13. HONG YH, Aziz N, Park JG, Lee D, et al
    The EEF1AKMT3/MAP2K7/TP53 axis suppresses tumor invasiveness and metastasis in gastric cancer.
    Cancer Lett. 2022;544:215803.
    PubMed     Abstract available

    May 2022
  14. HE J, Hu W, Ouyang Q, Zhang S, et al
    Helicobacter pylori infection induces stem cell-like properties in Correa cascade of gastric cancer.
    Cancer Lett. 2022 May 30:215764. doi: 10.1016/j.canlet.2022.215764.
    PubMed     Abstract available

    April 2022
  15. LIU X, Lu Y, Xu Y, Hou S, et al
    Corrigendum to "Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer" [Canc. Lett. 459 (2019 Sep 10) 122-134].
    Cancer Lett. 2022 Apr 29:215695. doi: 10.1016/j.canlet.2022.215695.

  16. YAMADA H, Takeshima H, Fujiki R, Yamashita S, et al
    ARID1A loss-of-function induces CpG island methylator phenotype.
    Cancer Lett. 2022;532:215587.
    PubMed     Abstract available

  17. CHEN T, Jinlin D, Wang F, Yuan Z, et al
    GSTM3 deficiency impedes DNA mismatch repair to promote gastric tumorigenesis via CAND1/NRF2-KEAP1 signaling.
    Cancer Lett. 2022 Apr 26:215692. doi: 10.1016/j.canlet.2022.215692.
    PubMed     Abstract available

    March 2022
  18. ZHANG JY, Du Y, Gong LP, Shao YT, et al
    ebv-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3.
    Cancer Lett. 2022;535:215646.
    PubMed     Abstract available

    February 2022
  19. ZHOU X, Fang D, Liu H, Ou X, et al
    PMN-MDSCs accumulation induced by CXCL1 promotes CD8(+) T cells exhaustion in gastric cancer.
    Cancer Lett. 2022 Feb 14:215598. doi: 10.1016/j.canlet.2022.215598.
    PubMed     Abstract available

    December 2021
  20. XU Y, Lu J, Tang Y, Xie W, et al
    PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages.
    Cancer Lett. 2021;529:19-36.
    PubMed     Abstract available

  21. DU Y, Zhang JY, Gong LP, Feng ZY, et al
    Hypoxia-induced ebv-circLMP2A promotes angiogenesis in EBV-associated gastric carcinoma through the KHSRP/VHL/HIF1alpha/VEGFA pathway.
    Cancer Lett. 2021 Dec 1. pii: S0304-3835(21)00605.
    PubMed     Abstract available

    November 2021
  22. MIYAMOTO S, Nagano Y, Miyazaki M, Nagamura Y, et al
    Integrin alpha5 mediates cancer cell-fibroblast adhesion and peritoneal dissemination of diffuse-type gastric carcinoma.
    Cancer Lett. 2021 Nov 12. pii: S0304-3835(21)00575.
    PubMed     Abstract available

  23. LI ZY, Xie Y, Deng M, Zhu L, et al
    c-Myc-activated intronic miR-210 and lncRNA MIR210HG synergistically promote the metastasis of gastric cancer.
    Cancer Lett. 2021 Nov 9. pii: S0304-3835(21)00572.
    PubMed     Abstract available

    October 2021
  24. ZHANG H, Ma RR, Zhang G, DongYi, et al
    Long noncoding RNA lnc-LEMGC combines with DNA-PKcs to suppress gastric cancer metastasis.
    Cancer Lett. 2021 Oct 6. pii: S0304-3835(21)00503.
    PubMed     Abstract available

    September 2021
  25. DAI W, Liu S, Zhang J, Pei M, et al
    Vorinostat triggers miR-769-5p/3p-mediated suppression of proliferation and induces apoptosis via the STAT3-IGF1R-HDAC3 complex in human gastric cancer.
    Cancer Lett. 2021 Sep 2. pii: S0304-3835(21)00437.
    PubMed     Abstract available

    August 2021
  26. SUGIMOTO A, Okuno T, Miki Y, Tsujio G, et al
    EMMPRIN in extracellular vesicles from peritoneal mesothelial cells stimulates the invasion activity of diffuse-type gastric cancer cells.
    Cancer Lett. 2021 Aug 30. pii: S0304-3835(21)00428.
    PubMed     Abstract available

  27. JIANG L, Chen Y, Min G, Wang J, et al
    Bcl2-associated athanogene 4 promotes the invasion and metastasis of gastric cancer cells by activating the PI3K/AKT/NF-kappaB/ZEB1 axis.
    Cancer Lett. 2021 Aug 19. pii: S0304-3835(21)00409.
    PubMed     Abstract available

    July 2021
  28. LIN DC, Zheng SY, Zhang ZG, Luo JH, et al
    TRPC3 promotes tumorigenesis of gastric cancer via the CNB2/GSK3beta/NFATc2 signaling pathway.
    Cancer Lett. 2021 Jul 23. pii: S0304-3835(21)00370.
    PubMed     Abstract available

    June 2021
  29. KOH V, Chakrabarti J, Torvund M, Steele N, et al
    Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids.
    Cancer Lett. 2021 Jun 11. pii: S0304-3835(21)00292.
    PubMed     Abstract available

  30. CHEN Y, Li Y, Qi C, Zhang C, et al
    Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patients.
    Cancer Lett. 2021;517:78-87.
    PubMed     Abstract available

  31. MILIOTIS C, Slack FJ
    miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer.
    Cancer Lett. 2021 Jun 4. pii: S0304-3835(21)00268.
    PubMed     Abstract available

    December 2020
  32. DAVERN M, Lysaght J
    Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers.
    Cancer Lett. 2020;495:89-99.
    PubMed     Abstract available

    October 2020
  33. ZHU S, Khalafi S, Chen Z, Poveda J, et al
    Silencing of miR490-3p by H. pylori activates DARPP-32 and induces resistance to gefitinib.
    Cancer Lett. 2020;491:87-96.
    PubMed     Abstract available

  34. TANG H, Kong Y, Guo J, Tang Y, et al
    Corrigendum to "Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22" [Canc. Lett. 340 (1) (Oct 28, 2013) 72-81].
    Cancer Lett. 2020 Oct 5. pii: S0304-3835(20)30356.

    September 2020
  35. YANG J, Liu Z, Zeng B, Hu G, et al
    Epstein-Barr virus-associated gastric cancer: A distinct subtype.
    Cancer Lett. 2020 Sep 23. pii: S0304-3835(20)30486.
    PubMed     Abstract available

  36. MA DH, Li BS, Liu JJ, Xiao YF, et al
    Corrigendum to 'miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway'[Cancer Lett. 2017 Nov 1;408:23-32].
    Cancer Lett. 2020 Sep 22. pii: S0304-3835(20)30470.

    March 2020
  37. WANG Y, Lu JH, Wang F, Wang YN, et al
    Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers.
    Cancer Lett. 2020;473:74-89.
    PubMed     Abstract available

  38. TAM BY, Chiu K, Chung H, Bossard C, et al
    The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models.
    Cancer Lett. 2020;473:186-197.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.